S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Advanced breast cancer; Cancer metastases; Lung cancer; Multiple myeloma; Prostate cancer; Solid tumours
- Focus Adverse reactions
- 31 Jan 2018 Planned End Date changed from 1 Jan 2018 to 1 Jun 2018.
- 31 Jan 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jun 2018.
- 12 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Jan 2018.